Filed: 5/15/2024ACC: 0001172661-24-002511
📋 What this filing means
SUVRETTA CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 101 equity positions with a total reported market value of $2.69B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
101
Positions
$2.69B
Total AUM (reported)
106.14M
Total Shares
Allocation by class
COM$1.63B60.4%
TR UNIT$235.38M8.7%
COM NEW$170.42M6.3%
COMMON STOCK$116.59M4.3%
CL A$98.02M3.6%
UNIT SER 1$86.58M3.2%
SPONSORED ADS$71.36M2.7%
Portfolio Concentration
Top 3$605.10M22.5%
4–10$587.01M21.8%
11–25$770.43M28.6%
Rest$730.09M27.1%
Top 3 weight
22.5%
Top 10 weight
44.3%
Voting Authority Distribution
Total shares with voting rights: 106.14M
Sole
Full voting authority
106.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole101
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings101
Rows:
SPDR S&P 500 ETF TR
SOLEShares450K
TypeSH
Market value$235.38M
8.74%
Sole
450K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares4M
TypeSH
Market value$218.93M
8.13%
Sole
4M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares7.07M
TypeSH
Market value$150.80M
5.60%
Sole
7.07M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares1.56M
TypeSH
Market value$108.66M
4.04%
Sole
1.56M
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares195K
TypeSH
Market value$86.58M
3.22%
Sole
195K
Shared
0.00
None
0.00
META PLATFORMS INC
SOLEShares173.60K
TypeSH
Market value$84.30M
3.13%
Sole
173.60K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares1.68M
TypeSH
Market value$78.29M
2.91%
Sole
1.68M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares7.88M
TypeSH
Market value$78.06M
2.90%
Sole
7.88M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares3.76M
TypeSH
Market value$77.80M
2.89%
Sole
3.76M
Shared
0.00
None
0.00
89BIO INC
SOLEShares6.30M
TypeSH
Market value$73.31M
2.72%
Sole
6.30M
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares2.25M
TypeSH
Market value$68.34M
2.54%
Sole
2.25M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares959.20K
TypeSH
Market value$66.38M
2.47%
Sole
959.20K
Shared
0.00
None
0.00
AMAZON COM INC
SOLEShares356.96K
TypeSH
Market value$64.39M
2.39%
Sole
356.96K
Shared
0.00
None
0.00
ADVANCED MICRO DEVICES INC
SOLEShares341.70K
TypeSH
Market value$61.67M
2.29%
Sole
341.70K
Shared
0.00
None
0.00
INSMED INC
SOLEShares2.02M
TypeSH
Market value$54.88M
2.04%
Sole
2.02M
Shared
0.00
None
0.00
THE CIGNA GROUP
SOLEShares137.14K
TypeSH
Market value$49.81M
1.85%
Sole
137.14K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares4.19M
TypeSH
Market value$49.72M
1.85%
Sole
4.19M
Shared
0.00
None
0.00
VERIZON COMMUNICATIONS INC
SOLEShares1.18M
TypeSH
Market value$49.49M
1.84%
Sole
1.18M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares121.90K
TypeSH
Market value$47.99M
1.78%
Sole
121.90K
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
SOLEShares5.11M
TypeSH
Market value$46.18M
1.72%
Sole
5.11M
Shared
0.00
None
0.00
GOLDMAN SACHS GROUP INC
SOLEShares109.89K
TypeSH
Market value$45.90M
1.70%
Sole
109.89K
Shared
0.00
None
0.00
TAIWAN SEMICONDUCTOR MFG LTD
SOLEShares329.35K
TypeSH
Market value$44.81M
1.66%
Sole
329.35K
Shared
0.00
None
0.00
AT&T INC
SOLEShares2.40M
TypeSH
Market value$42.22M
1.57%
Sole
2.40M
Shared
0.00
None
0.00
APOLLO GLOBAL MGMT INC
SOLEShares370.64K
TypeSH
Market value$41.68M
1.55%
Sole
370.64K
Shared
0.00
None
0.00
FERGUSON PLC NEW
SOLEShares169.28K
TypeSH
Market value$36.98M
1.37%
Sole
169.28K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 450K | SH | $235.38M 8.74% | 450K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 4M | SH | $218.93M 8.13% | 4M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 7.07M | SH | $150.80M 5.60% | 7.07M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 1.56M | SH | $108.66M 4.04% | 1.56M | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 195K | SH | $86.58M 3.22% | 195K | 0.00 | 0.00 |
META PLATFORMS INCSOLE | CL A | 173.60K | SH | $84.30M 3.13% | 173.60K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 1.68M | SH | $78.29M 2.91% | 1.68M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 7.88M | SH | $78.06M 2.90% | 7.88M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 3.76M | SH | $77.80M 2.89% | 3.76M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 6.30M | SH | $73.31M 2.72% | 6.30M | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 2.25M | SH | $68.34M 2.54% | 2.25M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 959.20K | SH | $66.38M 2.47% | 959.20K | 0.00 | 0.00 |
AMAZON COM INCSOLE | COM | 356.96K | SH | $64.39M 2.39% | 356.96K | 0.00 | 0.00 |
ADVANCED MICRO DEVICES INCSOLE | COM | 341.70K | SH | $61.67M 2.29% | 341.70K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 2.02M | SH | $54.88M 2.04% | 2.02M | 0.00 | 0.00 |
THE CIGNA GROUPSOLE | COM | 137.14K | SH | $49.81M 1.85% | 137.14K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 4.19M | SH | $49.72M 1.85% | 4.19M | 0.00 | 0.00 |
VERIZON COMMUNICATIONS INCSOLE | COM | 1.18M | SH | $49.49M 1.84% | 1.18M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 121.90K | SH | $47.99M 1.78% | 121.90K | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCSOLE | COM NEW | 5.11M | SH | $46.18M 1.72% | 5.11M | 0.00 | 0.00 |
GOLDMAN SACHS GROUP INCSOLE | COM | 109.89K | SH | $45.90M 1.70% | 109.89K | 0.00 | 0.00 |
TAIWAN SEMICONDUCTOR MFG LTDSOLE | SPONSORED ADS | 329.35K | SH | $44.81M 1.66% | 329.35K | 0.00 | 0.00 |
AT&T INCSOLE | COM | 2.40M | SH | $42.22M 1.57% | 2.40M | 0.00 | 0.00 |
APOLLO GLOBAL MGMT INCSOLE | COM | 370.64K | SH | $41.68M 1.55% | 370.64K | 0.00 | 0.00 |
FERGUSON PLC NEWSOLE | SHS | 169.28K | SH | $36.98M 1.37% | 169.28K | 0.00 | 0.00 |
Page 1 of 5
…